Science Explorer Back to mapMap
Discussion
Company · Uppsala · Sweden

Endovab Endovascular Development (Sweden)

endovab.comROR OpenAlex
Research works
8
▲ 88% vs 2018-21
Citations
15
1.8 per fractional work
Top-10% rate
6.1%
all institutions 10.0%
Open access
73%
world 40%
International
82%
world 18%
Endovab Endovascular Development (Sweden)

Not ranked overall: Endovab Endovascular Development (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Endovab Endovascular Development (Sweden) work in?

In all years, 84% of research at Endovab Endovascular Development (Sweden) is in Health Sciences, 12% in Physical Sciences. Its largest fields are Medicine (77%), Health Professions (7%), Engineering (6%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 84.3% of its workMedicine: 6 fractional works · 77.2% of its workPulmonary and Respiratory Medicine: 3 fractional works · 36.7% of its workSurgery: 2 fractional works · 20.9% of its workInternal Medicine: 1 fractional works · 8.2% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 2.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.1% of its workNeurology: 0 fractional works · 2.0% of its workBiochemistry: 0 fractional works · 0.9% of its workHematology: 0 fractional works · 0.9% of its workUrology: 0 fractional works · 0.9% of its workEpidemiology: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 7.1% of its workEmergency Medical Services: 1 fractional works · 7.1% of its workPhysical Sciences: 1 fractional works · 11.9% of its workEngineering: 0 fractional works · 6.1% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 4.0% of its workBiomedical Engineering: 0 fractional works · 2.1% of its workEnvironmental Science: 0 fractional works · 3.1% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 3.1% of its workMaterials Science: 0 fractional works · 2.7% of its workMaterials Chemistry: 0 fractional works · 2.1% of its workBiomaterials: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 2.5% of its workDecision Sciences: 0 fractional works · 2.5% of its workInformation Systems and Management: 0 fractional works · 2.5% of its workLife Sciences: 0 fractional works · 1.3% of its workNeuroscience: 0 fractional works · 1.3% of its workNeurology: 0 fractional works · 1.3% of its workALL ITS WORKEndovabEndovascular…8fractional works, all years
Life Sciences1%Physical Sciences12%Health Sciences84%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 7 fields, with their numbers
    1. Medicine677.2%
    2. Health Professions17.1%
    1. Engineering06.1%
    2. Environmental Science03.1%
    3. Materials Science02.7%
    1. Decision Sciences02.5%
    1. Neuroscience01.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Endovab Endovascular Development (Sweden)?

The most cited paper from Endovab Endovascular Development (Sweden) is "Impaired Vasoconstriction and Nitric Oxide-Mediated Relaxation in Pulmonary Arteries of Hypoxia- and Monocrotaline-Induced Pulmonary Hypertensive Rats" (Virak Mam, Alain F. Tanbe, Sally H. Vitali et al., 2009), with 77 citations. Next come "Protected Endovascular Revascularization of Subacute and Chronic Total Occlusion of the Internal Carotid Artery" (59) and "A journey in reversing practice patterns: a multidisciplinary experience in implementing DOQI guidelines for vascular access" (37).

Most cited papers
#PaperReleasedCitations
1 Impaired Vasoconstriction and Nitric Oxide-Mediated Relaxation in Pulmonary Arteries of Hypoxia- and Monocrotaline-Induced Pulmonary Hypertensive Rats Virak Mam, Alain F. Tanbe, Sally H. Vitali et al. · Journal of Pharmacology and Experimental Therapeutics Open access 13 Nov 2009 77
2 Protected Endovascular Revascularization of Subacute and Chronic Total Occlusion of the Internal Carotid Artery Masaaki Shojima, Shin Nemoto, Akio Morita et al. · American Journal of Neuroradiology Open access 22 Oct 2009 59
3 A journey in reversing practice patterns: a multidisciplinary experience in implementing DOQI guidelines for vascular access Alexandre Ackad, Gregory T. Simonian, Knight Steel et al. · Nephrology Dialysis Transplantation Open access 26 Apr 2005 37
4 Significance of Development and Reversion of Collaterals on MRI in Early Neurologic Improvement and Long-Term Functional Outcome after Intravenous Thrombolysis for Ischemic Stroke Masahiko Ichijo, Eri Iwasawa, Yoshiyuki Numasawa et al. · American Journal of Neuroradiology Open access 23 Jul 2015 29
5 Comparison of EVAR and open repair in patients with small abdominal aortic aneurysms: Can we predict results of the PIVOTAL trial? Purandath Lall, Péter Gloviczki, Gautam Agarwal et al. · Journal of Vascular Surgery Open access 2009 19
All 21 most cited papers, with filters and sorting

Which research topics does Endovab Endovascular Development (Sweden) publish most on?

By volume in 2022-now: Renal and Vascular Pathologies, Aortic aneurysm repair treatments, Venous Thromboembolism Diagnosis and Management and Vascular anomalies and interventions.

Renal and Vascular Patho…1Renal and Vascular Pathologies: 1 fractional worksAortic aneurysm repair treatments: 0 fractional worksVenous Thromboembolism Diagnosis and Management: 0 fractional worksVascular anomalies and interventions: 0 fractional worksCentral Venous Catheters and Hemodialysis: 0 fractional worksAbdominal vascular conditions and treatments: 0 fractional worksDiagnosis and Treatment …0Diagnosis and Treatment of Venous Diseases: 0 fractional worksClimate Change and Health Impacts: 0 fractional worksBusiness and Management Studies: 0 fractional worksInfectious Aortic and Vascular Conditions: 0 fractional works
Pulmonary and Respiratory MedicineInternal MedicineSurgeryEmergency Medical Services2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Renal and Vascular Pathologies Pulmonary and Respiratory Medicine 1 works
  2. 2 Aortic aneurysm repair treatments Pulmonary and Respiratory Medicine 0 works
  3. 3 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  4. 4 Vascular anomalies and interventions Surgery 0 works
  5. 5 Central Venous Catheters and Hemodialysis Emergency Medical Services 0 works
  6. 6 Abdominal vascular conditions and treatments Surgery 0 works
  7. 7 Diagnosis and Treatment of Venous Diseases Surgery 0 works
  8. 8 Climate Change and Health Impacts Health, Toxicology and Mutagenesis 0 works
  9. 9 Business and Management Studies Information Systems and Management 0 works
  10. 10 Infectious Aortic and Vascular Conditions Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available72.9%not open27.1%

World: 40% of research is openly available.

with international co-authors81.6%domestic only18.4%

World: 18% is written across borders.

How has Endovab Endovascular Development (Sweden)'s research output changed?

Output in 2022-2025 was 88% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Endovab Endovascular Development (Sweden) as a percentage of every work published that year, 0.0000036% in 2024.

still counting0.000020%0.000040%0.000060%Endovab Endovascular Development (Sweden)0.0000024% in 202520102020

Fractional works of Endovab Endovascular Development (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Uppsala

All research institutions in Uppsala

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Endovab Endovascular Development (Sweden). Posts are plain text and can be reported.